|
|
||||||||
Technical Briefs |
1 ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT;2 ARUP Laboratories, Salt Lake City, UT;3 Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT;4 Department of Medicine, University of Utah Health Sciences Center, Salt Lake City, UT;
aaddress correspondence to this author at: Division of Hematology, University of Utah Health Sciences Center, 50 North Medical Dr., Salt Lake City, UT 84132; fax 801-585-5469, e-mail george.rodgers@hsc.utah.edu
| The first 300 words of the full text of this article appear below. |
Accurate interpretation of pediatric coagulation tests is complicated by the fact that reference intervals for many assays differ from those for adults. In 1992, Andrew et al. (1) reported childhood coagulation reference intervals for ages 15, 610, and 1116 years with a minimum of 4 and maximum of 7 individuals at each age, with 2050 per age group. These results have served as the basis for most pediatric coagulation reference intervals for over a decade. However, with the development of newer reagents, methodologies, and instruments to measure coagulation analytes, results from this study, which was limited by its small size, may be less relevant.
In 2002, we initiated a project to collect blood and urine samples from healthy children 717 years of age, with the goal of establishing pediatric reference intervals for many laboratory tests (2). The purpose of this study was to determine pediatric reference intervals for 7 coagulation tests associated with common bleeding disorders.
Samples were drawn for reference interval studies from 902 healthy children, ages 717 years. All were healthy, had no history of bleeding or thrombotic disorders, and were taking no medications for at least 2 weeks before specimen collection. Informed consent was obtained from parents, and the study was approved by the University of Utah Institutional Review Board. Samples used to establish adult reference intervals were purchased from George King Bio-Medical or Precision Biologic, or were collected from local volunteers.
Blood was obtained by clean venipuncture; a pilot tube was drawn first. An exact ratio of 9 volumes of blood to 1 volume of anticoagulant (32 g/L citrate) was maintained. Specimens were centrifuged immediately at 3000g for 20 min at room temperature, aliquoted, and frozen at 80 °C.
Prothrombin time (PT); partial thromboplastin time (PTT); factors VIII, IX, and XI;
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |